Abstract: The present invention relates to a wound pad comprising fibers and being provided with at least a first and a second discrete group of incisions, wherein each one of said discrete groups of incisions comprises at least a first and a second incision, wherein said first and said second incision extend from a common starting point to a respective end point, wherein the end point of said first incision is spaced from the end point of said second incision, wherein the common starting point of said first group of incisions is provided on a first side of an imaginary line extending in the machine direction of said fibrous wound pad, and the common starting point of said second group of incisions is provided on a second side of said imaginary line, and wherein a first incision of said first group of incisions and a second incision of said second group of incisions each cross said imaginary line. The present invention also relates to a self-adhesive member for adhering to and cover a portion of a user's skin.

Abstract: The invention relates to a wound care product, comprising a wound care article located in a sterilized sealed chamber defining a sterile environment. The wound care product also comprises an openable and reclosable container which has at least one outer surface portion in said sterile environment. The invention further relates to a method for using such a wound care product.

Abstract: Undue scarring of healing wounds is decreased and/or the relapse rate of wounds is lowered by applying a composition that includes hemoglobin to the wound area. At least 40% of the hemoglobin in the composition is provided in CO-charged form.

Abstract: A medical dressing (30) is disclosed, comprising an adhesive layer (3) having a skin-facing surface (6) to adhere the medical dressing to a dermal surface, wherein said adhesive layer comprises a first chemical compound incorporated within said adhesive layer, and wherein at least a portion of said skin-facing surface comprises a coating (9) comprising a second chemical compound. Also disclosed is a method of manufacturing such a medical dressing.

Abstract: A wound dressing comprises a wound pad and a backing layer on a non-wound facing side of the backing layer. At least a portion of a sealing ring is provided within 5 mm of and continuously along the contour of the wound pad. A negative pressure wound treatment system comprising such a wound dressing is also disclosed.

Abstract: A silicone foam is described that is produced in-situ at a wound site, e.g. in a wound cavity, through a multi-component system, based on a physical foaming process, wherein the gas required to form the foam structure is provided through a blowing agent independently of the curing reaction of polyorganosiloxane components of the multi-component system. Therefore, the blowing agent is provided as a distinct entity of the multi-component system that is, in particular, not the result of any chemical reaction taking place in the multi-component system. A device for producing the foam and the corresponding negative pressure wound therapy kit are also described.

Abstract: Undue scarring of healing wounds is decreased and/or the relapse rate of wounds is lowered by applying a composition that includes hemoglobin to the wound area. At least 90% of the hemoglobin in the composition is provided in CO-charged form.

Abstract: The present invention refers to a composition, comprising hemoglobin or myoglobin, wherein in at least 40% of said hemoglobin or myoglobin the oxygen binding site is charged by a non-O2 ligand, and at least one further ingredient, a method for preparing said composition and the use of hemoglobin or myoglobin charged with a non-oxygen ligand for external treatment of wounds.

Abstract: Wound pads and systems and kits comprising wound pads whose total thickness can be modified by a user without the use of tools, comprising a plurality of separable layers having layer thicknesses less than the thickness of the wound pad. The wound pads may be used as wound fillers in the context of negative pressure wound therapy (also known as “vacuum treatment”, “reduced pressure” treatment).

Abstract: The present invention refers to a composition, comprising hemoglobin or myoglobin, wherein in at least 40% of said hemoglobin or myoglobin the oxygen binding site is charged by a non-O2 ligand, and at least one further ingredient, a method for preparing said composition and the use of hemoglobin or myoglobin charged with a non-oxygen ligand for external treatment of wounds.

Abstract: A method for preparing a composition for external treatment of wounds includes charging at least 90% of the oxygen binding sites of hemoglobin with carbon monoxide during or after isolation from its natural environment. The method further includes adding at least one further ingredient selected from the group consisting of electrolyte(s), preservative(s), stabilizer(s), anti-flocculant(s), anticoagulant(s), pH buffering agent(s), solvent(s), antioxidant(s), film-forming agent(s) and crosslinking agent(s). The method can further include packaging the composition, such as in an aerosol can.

Abstract: The present invention relates to a system and method for support and off-loading. The system includes an inner bladder filled with a flowable composition. An outer bladder filled with a flowable composition is positioned adjacent to the inner bladder. The composition of the inner bladder has greater flow characteristics than the composition of the outer bladder. The inner bladder micro-contours to the received body part and the outer bladder macro-contours to the inner bladder after the inner bladder is micro-contoured to the received body part. Alternatively, the system provides a pair of ultra low pressure plenums and a positioner. The patient body size and size and corresponding surface area of the positioner control the amount of gas which is displaced evenly against the walls of the ultra low pressure plenums.

Abstract: A medical dressing for application at a treatment area of a human body is provided. The dressing comprises a border area surrounding a central inspection area which is intended to be placed over said treatment area. The dressing also comprises a pad which may be arranged in the central inspection area and may be at least partly removed from the central inspection area for enabling visual inspection of the treatment area. There is also provided a medical dressing system and a method for reducing the workload for nursing personnel.

Abstract: A method of producing a hydrophilic polyurethane foam structure containing inert activated carbon particles, includes the steps of: (a) providing a water phase containing a surfactant and dispersed inert particles; (b) providing a isocyanate-terminated polyether having functionality of more than 2; (c) mixing the water phase and the isocyanate-terminated polyether, immediately transferring the resulting mixture to a mold or a continuous web, whereby a foam structure is obtained; and (d) drying the foam structure until it has a moisture content of at most 10% (wt). A foam structure produced by the method and a wound dressing containing the foam structure are also disclosed.